Aveanna Healthcare (NASDAQ:AVAH) Hits New 52-Week High – Still a Buy?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) reached a new 52-week high during trading on Wednesday . The stock traded as high as $14.05 and last traded at $14.02, with a volume of 3133106 shares changing hands. The stock had previously closed at $13.66.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Wall Street Zen cut Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Barclays upped their price objective on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the stock an “overweight” rating in a report on Friday, August 28th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Finally, Royal Bank Of Canada lifted their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 24th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $13.50.

Aveanna Healthcare Stock Up 2.6%

The company has a market capitalization of $3.06 billion, a PE ratio of 11.40, a P/E/G ratio of 0.85 and a beta of 1.97. The stock’s fifty day moving average is $10.89 and its two-hundred day moving average is $8.40. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. As a group, analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current year.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $143,704,885.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Robert Williams, Jr. sold 14,500,002 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $166,750,023.00. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 59,904,505 shares of company stock valued at $649,301,514. Company insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of AVAH. Caitong International Asset Management Co. Ltd grew its position in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after purchasing an additional 2,400 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare during the 2nd quarter worth about $43,000. Summit Securities Group LLC purchased a new stake in Aveanna Healthcare during the 1st quarter worth about $53,000. Oxford Asset Management LLP bought a new position in Aveanna Healthcare in the 2nd quarter worth about $64,000. Finally, C M Bidwell & Associates Ltd. purchased a new position in Aveanna Healthcare during the 2nd quarter valued at about $69,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.